Download PDF
Thromb Haemost 1988; 59(01): 121
DOI: 10.1055/s-0038-1642577
Review Article
Schattauer GmbH Stuttgart

The Relationship between Defective Heparin Cofactor Activities and Thrombotic Phenomena in AT III Abnormalities

Antonio Girolami
University of Padua Medical School, Institute of Medical Semeiotics and II Chair Medicine, Via Ospedale 105, 35100 Padua, Italy
,
Anna Rosa Lazzaro
University of Padua Medical School, Institute of Medical Semeiotics and II Chair Medicine, Via Ospedale 105, 35100 Padua, Italy
,
Paolo Simioni
University of Padua Medical School, Institute of Medical Semeiotics and II Chair Medicine, Via Ospedale 105, 35100 Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 19 August 1987

Accepted after revision 01 October 1987

Publication Date:
18 April 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Mannucci P.M., Tripodi A.. Laboratory screening of inherited thrombotic syndromes. Thromb Haemostas 1987; 57: 247-51
    PubMedGoogle Scholar
  • 2 Chasse JF, Esnard F, Guitton J, Mouray H, Perigois F, Fauconneau G, Gauthier F. An abnormal plasma antithrombin with no apparent affinity for heparin. Thromb Res 1984; 50: 297-302
    PubMedGoogle Scholar
  • 3 Fischer AM, Gazengel C, Dautzenberg MD, Benhammo J, Béguin S, Vergoz D. A new case of abnormal antithrombin III (AT III): biological characteristics and thromboembolic accidents management. Thromb Haemostas 1983; 50: 358 (Abstr)
    PubMedGoogle Scholar
  • 4 Fischer AM, Cornu P, Sternberg C, Mériane F, Chafa O, Dautzenberg MD, Béguin S, Desnos M. Antithrombin III Alger: a new homozygous AT III variant. Thromb Haemostas 1986; 55: 218-21
    PubMedGoogle Scholar
  • 5 Girolami A, Pengo V, Patrassi GM, Cappellato G, Vianello C, Cartei L. Antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease. Folia Haematol 1983; 110: 98-111
    PubMedGoogle Scholar
  • 6 Girolami A, Fabris F, Cappellato G, Sainati L, Boeri G. Antithrombin III Padua: a new congenital abnormality with defective heparin cofactor activities but no thrombotic disease. Blut 1983; 47: 93-103
    CrossrefPubMedGoogle Scholar
  • 7 Girolami A, Marafioti F, Rubertelli M, Vicarioto MA, Cappellato G, Mazzuccato M. Antithrombin III Trento: a new congenital AT III abnormality with peculiar crossed immunoelectrophoretic pattern in the absence of heparin. Acta Haematol 1984; 72: 73-82
    CrossrefPubMedGoogle Scholar
  • 8 Girolami A. The incidence of thrombotic manifestations in AT III abnormalities. Thromb Haemostas 1987; 57: 123
    PubMedGoogle Scholar
  • 9 Girolami A. A tentative classification of AT III congenital abnormalities. Folia Haematol (in press)
    Google Scholar
  • 10 Koide T, Takahashi K, Odami S, Ono T, Sakuragawa N. Isolation and characterization of a hereditary abnormal antithrombin III “antithrombin Tokoama”. Thromb Res 1983; 31: 319-328
    CrossrefPubMedGoogle Scholar
  • 11 Boyer C, Wolf M, Vedrenne J, Meyer D, Larrieu MJ. Homozygous variant of Antithrombin III: AT III Fantainebleau. Thromb Haemostas 1986; 56: 18-22
    PubMedGoogle Scholar
  • 12 Moerloose PA, de Reber G, Vernet Ph, Minazio Ph, Bouvier CA. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity. Thromb Haemostas 1987; 57: 154-7
    PubMedGoogle Scholar
  • 13 Penner JA, Hassouna H, Hunter MJ, Chockley M. A clinically silent antithrombin III defect in an Ann Arbor family. Thromb Haemostas 1979; 42: 186 (Abstr)
    PubMedGoogle Scholar
  • 14 Tran TH, Bounameaux H, Bondeli C, Honkanen H, Marbet GA, Duckcrt F. Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis. Thromb Haemostas 1980; 44: 87-91
    PubMedGoogle Scholar
  • 15 Wolf M, Boyer C, Lavergne JM, Larrieu MJ. A new familial variant of antithrombin III: antithrombin III Paris. Br J Haematol 1982; 51: 285-95
    CrossrefPubMedGoogle Scholar